Integrated into a worldwide network of clinical and academic partners, Fraunhofer MEVIS develops real-world software systems for image-based early detection, diagnosis, and therapy. Fraunhofer MEVIS focuses on cancer as well as diseases of the cardiovascular system, brain, breast, liver, and lung. The goal is to detect diseases earlier and more reliably, to customize the treatment to the individual needs of a patient, and to quantify therapy outcomes.
Fraunhofer MEVIS cooperates closely with industrial partners from medical technology and pharmacology, thereby covering the entire chain from applied research to certified medical products. Through six professorships, Fraunhofer MEVIS maintains close ties with five universities: the University of Bremen, Jacobs University, University of Lübeck, Radboud University Nijmegen, and Harvard University. Since 2011, Fraunhofer MEVIS has operated its own 3-Tesla magnetic resonance imaging scanner at the University of Bremen.
MEVIS was founded in 1995 as a non-profit research center at the University of Bremen. Since January 2009, it has been an institute of the Fraunhofer-Gesellschaft, the leading organization for applied research in Europe.